Global and United States NGS Based Diagnostics Market Report & Forecast 2024-2031

Report ID: 1860760 | Published Date: Feb 2026 | No. of Page: 98 | Base Year: 2025 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Study Coverage
    1.1 NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global NGS Based Diagnostics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global NGS Based Diagnostics Market Size for the Year 2017-2028
        1.2.2 Global NGS Based Diagnostics Market Size for the Year 2017-2028
    1.3 NGS Based Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States NGS Based Diagnostics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of NGS Based Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 NGS Based Diagnostics Market Dynamics
        1.4.1 NGS Based Diagnostics Industry Trends
        1.4.2 NGS Based Diagnostics Market Drivers
        1.4.3 NGS Based Diagnostics Market Challenges
        1.4.4 NGS Based Diagnostics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 NGS Based Diagnostics by Type
    2.1 NGS Based Diagnostics Market Segment by Type
        2.1.1 DNA Sequencing
        2.1.2 RNA Sequencing
        2.1.3 Whole Genome Sequencing
        2.1.4 Whole Exome Sequencing
        2.1.5 Other
    2.2 Global NGS Based Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.3 Global NGS Based Diagnostics Market Size by Type (2017-2028)
    2.4 United States NGS Based Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.5 United States NGS Based Diagnostics Market Size by Type (2017-2028)
3 NGS Based Diagnostics by Application
    3.1 NGS Based Diagnostics Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Academics/Research Institutions
    3.2 Global NGS Based Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.3 Global NGS Based Diagnostics Market Size by Application (2017-2028)
    3.4 United States NGS Based Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.5 United States NGS Based Diagnostics Market Size by Application (2017-2028)
4 Global NGS Based Diagnostics Competitor Landscape by Company
    4.1 Global NGS Based Diagnostics Market Size by Company
        4.1.1 Top Global NGS Based Diagnostics Companies Ranked by Revenue (2021)
        4.1.2 Global NGS Based Diagnostics Revenue by Player (2017-2022)
    4.2 Global NGS Based Diagnostics Concentration Ratio (CR)
        4.2.1 NGS Based Diagnostics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of NGS Based Diagnostics in 2021
        4.2.3 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global NGS Based Diagnostics Headquarters, Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global NGS Based Diagnostics Headquarters and Area Served
        4.3.2 Global NGS Based Diagnostics Companies Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into NGS Based Diagnostics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States NGS Based Diagnostics Market Size by Company
        4.5.1 Top NGS Based Diagnostics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States NGS Based Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global NGS Based Diagnostics Market Size by Region
    5.1 Global NGS Based Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global NGS Based Diagnostics Market Size by Region (2017-2028)
        5.2.1 Global NGS Based Diagnostics Market Size by Region: 2017-2022
        5.2.2 Global NGS Based Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America NGS Based Diagnostics Market Size YoY Growth 2017-2028
        6.1.2 North America NGS Based Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific NGS Based Diagnostics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific NGS Based Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe NGS Based Diagnostics Market Size YoY Growth 2017-2028
        6.3.2 Europe NGS Based Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America NGS Based Diagnostics Market Size YoY Growth 2017-2028
        6.4.2 Latin America NGS Based Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa NGS Based Diagnostics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa NGS Based Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Janssen
        7.1.1 Janssen Company Details
        7.1.2 Janssen Business Overview
        7.1.3 Janssen NGS Based Diagnostics Introduction
        7.1.4 Janssen Revenue in NGS Based Diagnostics Business (2017-2022)
        7.1.5 Janssen Recent Development
    7.2 Roche
        7.2.1 Roche Company Details
        7.2.2 Roche Business Overview
        7.2.3 Roche NGS Based Diagnostics Introduction
        7.2.4 Roche Revenue in NGS Based Diagnostics Business (2017-2022)
        7.2.5 Roche Recent Development
    7.3 Qiagen
        7.3.1 Qiagen Company Details
        7.3.2 Qiagen Business Overview
        7.3.3 Qiagen NGS Based Diagnostics Introduction
        7.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2017-2022)
        7.3.5 Qiagen Recent Development
    7.4 ThermoFisher Scientific
        7.4.1 ThermoFisher Scientific Company Details
        7.4.2 ThermoFisher Scientific Business Overview
        7.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction
        7.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2017-2022)
        7.4.5 ThermoFisher Scientific Recent Development
    7.5 Oxford Gene Technology
        7.5.1 Oxford Gene Technology Company Details
        7.5.2 Oxford Gene Technology Business Overview
        7.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction
        7.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2017-2022)
        7.5.5 Oxford Gene Technology Recent Development
    7.6 Illumina
        7.6.1 Illumina Company Details
        7.6.2 Illumina Business Overview
        7.6.3 Illumina NGS Based Diagnostics Introduction
        7.6.4 Illumina Revenue in NGS Based Diagnostics Business (2017-2022)
        7.6.5 Illumina Recent Development
    7.7 Pacific Biosciences
        7.7.1 Pacific Biosciences Company Details
        7.7.2 Pacific Biosciences Business Overview
        7.7.3 Pacific Biosciences NGS Based Diagnostics Introduction
        7.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2017-2022)
        7.7.5 Pacific Biosciences Recent Development
    7.8 Paradigm Diagnostics
        7.8.1 Paradigm Diagnostics Company Details
        7.8.2 Paradigm Diagnostics Business Overview
        7.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction
        7.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        7.8.5 Paradigm Diagnostics Recent Development
    7.9 Innogene Kalbiotech
        7.9.1 Innogene Kalbiotech Company Details
        7.9.2 Innogene Kalbiotech Business Overview
        7.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction
        7.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2017-2022)
        7.9.5 Innogene Kalbiotech Recent Development
    7.10 Admera Health
        7.10.1 Admera Health Company Details
        7.10.2 Admera Health Business Overview
        7.10.3 Admera Health NGS Based Diagnostics Introduction
        7.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2017-2022)
        7.10.5 Admera Health Recent Development
    7.11 AITbiotech
        7.11.1 AITbiotech Company Details
        7.11.2 AITbiotech Business Overview
        7.11.3 AITbiotech NGS Based Diagnostics Introduction
        7.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2017-2022)
        7.11.5 AITbiotech Recent Development
    7.12 Centogene
        7.12.1 Centogene Company Details
        7.12.2 Centogene Business Overview
        7.12.3 Centogene NGS Based Diagnostics Introduction
        7.12.4 Centogene Revenue in NGS Based Diagnostics Business (2017-2022)
        7.12.5 Centogene Recent Development
    7.13 Phalanx Biotech Group
        7.13.1 Phalanx Biotech Group Company Details
        7.13.2 Phalanx Biotech Group Business Overview
        7.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction
        7.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2017-2022)
        7.13.5 Phalanx Biotech Group Recent Development
    7.14 iGenomX
        7.14.1 iGenomX Company Details
        7.14.2 iGenomX Business Overview
        7.14.3 iGenomX NGS Based Diagnostics Introduction
        7.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2017-2022)
        7.14.5 iGenomX Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. NGS Based Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. NGS Based Diagnostics Market Trends
    Table 3. NGS Based Diagnostics Market Drivers
    Table 4. NGS Based Diagnostics Market Challenges
    Table 5. NGS Based Diagnostics Market Restraints
    Table 6. Global NGS Based Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States NGS Based Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global NGS Based Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States NGS Based Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top NGS Based Diagnostics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global NGS Based Diagnostics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global NGS Based Diagnostics Revenue Share by Player, 2017-2022
    Table 13. Global NGS Based Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global NGS Based Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)
    Table 15. Top Players of NGS Based Diagnostics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into NGS Based Diagnostics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top NGS Based Diagnostics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States NGS Based Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States NGS Based Diagnostics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global NGS Based Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global NGS Based Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global NGS Based Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America NGS Based Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific NGS Based Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe NGS Based Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa NGS Based Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa NGS Based Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Janssen Company Details
    Table 31. Janssen Business Overview
    Table 32. Janssen NGS Based Diagnostics Product
    Table 33. Janssen Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 34. Janssen Recent Development
    Table 35. Roche Company Details
    Table 36. Roche Business Overview
    Table 37. Roche NGS Based Diagnostics Product
    Table 38. Roche Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 39. Roche Recent Development
    Table 40. Qiagen Company Details
    Table 41. Qiagen Business Overview
    Table 42. Qiagen NGS Based Diagnostics Product
    Table 43. Qiagen Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 44. Qiagen Recent Development
    Table 45. ThermoFisher Scientific Company Details
    Table 46. ThermoFisher Scientific Business Overview
    Table 47. ThermoFisher Scientific NGS Based Diagnostics Product
    Table 48. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 49. ThermoFisher Scientific Recent Development
    Table 50. Oxford Gene Technology Company Details
    Table 51. Oxford Gene Technology Business Overview
    Table 52. Oxford Gene Technology NGS Based Diagnostics Product
    Table 53. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 54. Oxford Gene Technology Recent Development
    Table 55. Illumina Company Details
    Table 56. Illumina Business Overview
    Table 57. Illumina NGS Based Diagnostics Product
    Table 58. Illumina Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 59. Illumina Recent Development
    Table 60. Pacific Biosciences Company Details
    Table 61. Pacific Biosciences Business Overview
    Table 62. Pacific Biosciences NGS Based Diagnostics Product
    Table 63. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 64. Pacific Biosciences Recent Development
    Table 65. Paradigm Diagnostics Company Details
    Table 66. Paradigm Diagnostics Business Overview
    Table 67. Paradigm Diagnostics NGS Based Diagnostics Product
    Table 68. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 69. Paradigm Diagnostics Recent Development
    Table 70. Innogene Kalbiotech Company Details
    Table 71. Innogene Kalbiotech Business Overview
    Table 72. Innogene Kalbiotech NGS Based Diagnostics Product
    Table 73. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 74. Innogene Kalbiotech Recent Development
    Table 75. Admera Health Company Details
    Table 76. Admera Health Business Overview
    Table 77. Admera Health NGS Based Diagnostics Product
    Table 78. Admera Health Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 79. Admera Health Recent Development
    Table 80. AITbiotech Company Details
    Table 81. AITbiotech Business Overview
    Table 82. AITbiotech NGS Based Diagnostics Product
    Table 83. AITbiotech Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 84. AITbiotech Recent Development
    Table 85. Centogene Company Details
    Table 86. Centogene Business Overview
    Table 87. Centogene NGS Based Diagnostics Product
    Table 88. Centogene Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 89. Centogene Recent Development
    Table 90. Phalanx Biotech Group Company Details
    Table 91. Phalanx Biotech Group Business Overview
    Table 92. Phalanx Biotech Group NGS Based Diagnostics Product
    Table 93. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 94. Phalanx Biotech Group Recent Development
    Table 95. iGenomX Company Details
    Table 96. iGenomX Business Overview
    Table 97. iGenomX NGS Based Diagnostics Product
    Table 98. iGenomX Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 99. iGenomX Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. NGS Based Diagnostics Product Picture
    Figure 2. Global NGS Based Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global NGS Based Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 4. United States NGS Based Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States NGS Based Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 6. United States NGS Based Diagnostics Market Share in Global 2017-2028
    Figure 7. NGS Based Diagnostics Report Years Considered
    Figure 8. Product Picture of DNA Sequencing
    Figure 9. Product Picture of RNA Sequencing
    Figure 10. Product Picture of Whole Genome Sequencing
    Figure 11. Product Picture of Whole Exome Sequencing
    Figure 12. Product Picture of Other
    Figure 13. Global NGS Based Diagnostics Market Share by Type in 2022 & 2028
    Figure 14. Global NGS Based Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global NGS Based Diagnostics Market Share by Type (2017-2028)
    Figure 16. United States NGS Based Diagnostics Market Share by Type in 2022 & 2028
    Figure 17. United States NGS Based Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States NGS Based Diagnostics Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Academics/Research Institutions
    Figure 22. Global NGS Based Diagnostics Market Share by Application in 2022 & 2028
    Figure 23. Global NGS Based Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global NGS Based Diagnostics Market Share by Application (2017-2028)
    Figure 25. United States NGS Based Diagnostics Market Share by Application in 2022 & 2028
    Figure 26. United States NGS Based Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States NGS Based Diagnostics Market Share by Application (2017-2028)
    Figure 28. North America NGS Based Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe NGS Based Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific NGS Based Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America NGS Based Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa NGS Based Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE NGS Based Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 58. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 59. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 60. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 61. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 62. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 63. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 64. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 65. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 66. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 67. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 68. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 69. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Frequently Asked Questions
NGS Based Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
NGS Based Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
NGS Based Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Night Vision Goggles

Night Vision Goggles market is segmented by region (country), players, by Type and by Application ... Read More

Nocturia

Nocturia market is segmented by region (country), players, by Type and by Application. Players, s ... Read More

Aircraft Radome

Aircraft Radome market is segmented by region (country), players, by Type and by Application. Pla ... Read More